ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02985957
Brief Title: A Study to Evaluate Preliminary Safety and Efficacy of Nivolumab Plus Ipilimumab in Men With Metastatic Castration-Resistant Prostate Cancer (CheckMate 650)

First Submitted : November 22, 2016
First Submitted that Met QC Criteria : December 5, 2016
First Posted : December 7, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : June 18, 2018
Last Update Posted : June 19, 2018